Brompheniramine Maleate 12 mg Slow Release (MEM4) Oral Capsules are specially formulated with Methocel E4M, a controlled-release polymer. This innovative design allows for the gradual release of the active ingredient, Brompheniramine Maleate, over an extended period of time. The slow-release mechanism offers sustained therapeutic effects, reducing the need for frequent dosing and enhancing patient compliance.
These capsules are primarily used in the treatment of various disease states. Brompheniramine Maleate is an antihistamine, commonly used to alleviate symptoms of allergies, the common cold, and other upper respiratory conditions. By providing a controlled and prolonged release profile, these capsules ensure consistent relief from these conditions, improving the overall quality of patient care.
The Brompheniramine Maleate 12 mg Slow Release (MEM4) Oral Capsules are a specially formulated medication designed to provide a controlled and prolonged release of the active ingredient, Brompheniramine Maleate. This formulation is encapsulated with Methocel E4M, a type of controlled-release polymer. The use of this polymer ensures that the medication is gradually released over an extended period of time, providing sustained therapeutic effects.
Brompheniramine Maleate is an antihistamine used to treat symptoms of allergies and the common cold. These symptoms may include itching, watery eyes, runny nose, and sneezing. By blocking a certain natural substance (histamine) that your body makes during an allergic reaction, Brompheniramine Maleate helps alleviate these symptoms. The slow-release formulation ensures a steady level of medication in your body, reducing the need for frequent dosing and improving patient compliance.
It's important to note that Brompheniramine Maleate does not prevent or treat a serious allergic reaction (anaphylaxis) and should not be used for asthma or other breathing problems. It is also not intended to treat ongoing cough caused by smoking or long-term breathing problems (such as chronic bronchitis, emphysema) unless directed by your doctor.
The Brompheniramine Maleate 12 mg Slow Release (MEM4) Oral Capsules are intended for oral administration. The dosage is determined by the prescriber based on the patient's age, medical condition, and response to treatment. It is crucial to take this medication as directed by your healthcare provider to ensure its effectiveness.
As with any medication, Brompheniramine Maleate may cause side effects. Common side effects may include drowsiness, dizziness, dry mouth/nose/throat, headache, upset stomach, constipation, or trouble sleeping. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.
If you have any questions or concerns about the Brompheniramine Maleate 12 mg Slow Release (MEM4) Oral Capsules, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is here to assist you.
Brompheniramine Maleate is an antihistamine used to relieve symptoms of allergy, hay fever, and the common cold. These symptoms include rash, watery eyes, itchy eyes/nose/throat/skin, cough, runny nose, and sneezing. This medication works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Its drying effects on such symptoms as watery eyes and runny nose are caused by blocking another natural substance made by your body (acetylcholine).
While Brompheniramine Maleate is generally safe for use, it can interact with other medications, potentially altering their effects or increasing the risk of side effects. It is important to inform your healthcare provider of all medications you are currently taking, including prescription drugs, over-the-counter medications, vitamins, and herbal supplements.
Brompheniramine Maleate may interact with other antihistamines, drugs for sleep or anxiety (such as alprazolam, diazepam, zolpidem), muscle relaxants, and narcotic pain relievers (such as codeine). Check the labels on all your medicines (such as allergy or cough-and-cold products) because they may contain ingredients that cause drowsiness. Ask your pharmacist about using those products safely.
Additionally, Brompheniramine Maleate can interact with MAO inhibitors (Isocarboxazid, linezolid, methylene blue, moclobemide, phenelzine, procarbazine, rasagiline, safinamide, selegiline, tranylcypromine) during treatment and for two weeks after stopping treatment. Taking MAO inhibitors with this medication may cause a serious (possibly fatal) drug interaction. Avoid taking MAO inhibitors and inform your doctor or pharmacist if you are taking any of these medications.
Furthermore, Brompheniramine Maleate can cause drowsiness. Alcohol or marijuana (cannabis) can make you more drowsy. Do not drive, use machinery, or do anything that needs alertness until you can do it safely. Avoid alcoholic beverages. Talk to your doctor if you are using marijuana (cannabis).
It is also important to note that Brompheniramine Maleate can affect the results of certain laboratory tests (including allergy skin testing), possibly causing false test results. Make sure laboratory personnel and all your doctors know you use this drug.
If you have any questions about the potential interactions of Brompheniramine Maleate, or if you experience any unexpected side effects, please reach out to us at Bayview Pharmacy. We are here to help ensure your medication regimen is safe and effective for you.
Brompheniramine Maleate 12 mg Slow Release (MEM4) Oral Capsules are a unique formulation designed to provide a controlled and prolonged release of the active ingredient, Brompheniramine Maleate. This is achieved through the use of Methocel E4M, a type of controlled-release polymer. The polymer encapsulates the medication, allowing it to be released gradually over an extended period of time.
The slow release of Brompheniramine Maleate provides sustained therapeutic effects, which can be beneficial in the treatment of various disease states. Brompheniramine Maleate is an antihistamine, which works by blocking the effects of histamine, a substance in the body that causes allergic symptoms. It is commonly used to relieve symptoms of allergies, such as runny nose, sneezing, itching, and watery eyes.
By using a slow-release formulation, the frequency of dosing can be reduced. This can improve patient compliance, as it is often easier for patients to remember to take their medication when it is required less frequently. Furthermore, the sustained release of the medication can provide more consistent relief of symptoms, as the levels of the medication in the body do not fluctuate as much as with immediate-release formulations.
For prescribers, it is important to note that the slow-release formulation of Brompheniramine Maleate may not be suitable for all patients. It should not be used in patients with a hypersensitivity to Brompheniramine Maleate or any of the excipients in the formulation. Additionally, it should be used with caution in patients with certain medical conditions, such as glaucoma, urinary retention, and severe cardiovascular disease.
If you have any questions about Brompheniramine Maleate 12 mg Slow Release (MEM4) Oral Capsules, or if you would like more information about how this formulation works, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is always here to help.
Brompheniramine Maleate is a well-studied antihistamine widely used for managing symptoms related to allergenic conditions such as runny nose, sneezing, itching, and watery eyes triggered by hay fever, the common cold, or other upper respiratory allergies. However, its applications extend beyond treating these common disease states.
For instance, Brompheniramine Maleate's antihistaminic properties have also shown promise for helping manage itchy skin conditions related to hives and dermatitis, potentially reducing discomfort and improving quality of life. It's important to note, however, that Brompheniramine Maleate should not be the primary method of treating chronic skin conditions. It should instead be used to supplement comprehensive treatment programs prescribed by a qualified healthcare provider.
In some cases, healthcare providers may suggest Brompheniramine Maleate as an adjunct treatment for sleep disturbances. Because it can cause drowsiness as a side effect, it may assist individuals struggling with sleep due to temporary fluctuations in schedule, stress, jet lag, or mild insomnia. However, it's crucial not to use this medication regularly for sleep, as it can contribute to developing dependency.
Although the Brompheniramine Maleate 12 mg Slow Release Oral Capsules are designed primarily for allergy management, their controlled-release feature can also benefit patients requiring consistent, round-the-clock symptom control in these additional applications. This slow-release mechanism provides extended protection, reducing the needs for frequent dosing, often increasing patient adherence to the medication regimen. It's critical, though, to follow the prescribing healthcare professional's guidance when changing the intended use of the medication or when expanding its use to include secondary benefits.
Any other alternative use of Brompheniramine Maleate should always be consulted by a healthcare provider. They can provide precise information about the potential benefits and risks, along with the safe and effective use of the drug based on various health factors, ensuring you derive the maximum benefits with minimal risks. If you have any further questions or need additional information, feel free to reach out to us at Bayview Pharmacy.
This is a medication encapsulated in Methocel E4M, a type of controlled-release polymer. It is designed to release the active ingredient gradually over an extended period, providing lasting therapeutic effects. This slow-release approach can improve patient compliance and reduce dosing frequency for medications requiring a controlled, prolonged release.
Methocel E4M is a type of controlled-release polymer used in pharmaceuticals for its gradual and extended release properties. It helps in reducing dosing frequency and improving patient compliance by offering sustained therapeutic effects.
This medication is designed to slowly release the active ingredient, which can lead to sustained therapeutic effects. Also, the reduced frequency of dosage may improve patient compliance and acceptance of this medication.
Methocel E4M aids in gradual and extended release of encapsulated medication or active ingredients. This contributes towards maintaining a consistent therapeutic effect in the body, reduced dosing frequency and increased patient compliance.
This phrase refers to a dosing strategy where the medication or active ingredient is released steadily into the body over an extended period of time. This controlled release ensures a constant therapeutic effect, requires fewer doses, and contributes to better patient compliance.
Due to the controlled-release mechanism provided by Methocel E4M, the effects of this medication are meant to last over an extended period of time. The exact length can vary based on individual patient differences. Consult with your healthcare provider for specific details.
One of the main advantages of Brompheniramine Maleate 12 mg Slow Release (MEM4) Oral Capsules is the reduced frequency of dosing due to its controlled and prolonged release properties. The exact dosing instructions should be determined by your healthcare provider.
No, the slow release of the medication is designed to maintain its therapeutic effect over an extended period. This method of administration can actually contribute to improved treatment outcomes and patient compliance with the dosing regimen.
These capsules are suitable for patients who require Brompheniramine Maleate, and benefit from medication that has a controlled and prolonged release. However, suitability should be determined by a healthcare provider who knows the specific needs and conditions of a patient.
As with any medication, potential side effects may occur. However, the slow release formulation can possibly reduce the intensity of certain side effects compared to immediate-release formulations. For detailed information regarding potential side effects, please consult your healthcare provider.